Limitations
tumor, early-stage cervical cancer
TUMOR, METASTATIC DISEASE
This study has shortcomings; when a negative washing cytology result is obtained, although it is technically tumor-free, it does not mean that the prognosis of the tumor is good, and there may be unexpected metastatic disease. At this time, it should be interpreted carefully in conjunction with the pathological results. In addition, using the endocutter can increase potential surgical costs. Although the sample size of this report is still small and the follow-up time is short, further long-term follow-up data will be supplemented in the future as this trial is still ongoing at the time of this report. Nevertheless, the findings strengthen our confidence in the continued use of MIS for patients with early-stage cervical cancer.